Literature DB >> 32066837

Long-lived regulatory T cells generated during severe bronchiolitis in infancy influence later progression to asthma.

Jason P Lynch1,2, Rhiannon B Werder1,2, Bodie F Curren1,2, Md Al Amin Sikder1,2, Ashik Ullah1, Ismail Sebina1, Ridwan B Rashid1,2, Vivian Zhang1,2, John W Upham3,4, Geoff R Hill5, Raymond J Steptoe3, Simon Phipps6,7.   

Abstract

The type-2 inflammatory response that promotes asthma pathophysiology occurs in the absence of sufficient immunoregulation. Impaired regulatory T cell (Treg) function also predisposes to severe viral bronchiolitis in infancy, a major risk factor for asthma. Hence, we hypothesized that long-lived, aberrantly programmed Tregs causally link viral bronchiolitis with later asthma. Here we found that transient plasmacytoid dendritic cell (pDC) depletion during viral infection in early-life, which causes the expansion of aberrant Tregs, predisposes to allergen-induced or virus-induced asthma in later-life, and is associated with altered airway epithelial cell (AEC) responses and the expansion of impaired, long-lived Tregs. Critically, the adoptive transfer of aberrant Tregs (unlike healthy Tregs) to asthma-susceptible mice failed to prevent the development of viral-induced or allergen-induced asthma. Lack of protection was associated with increased airway epithelial cytoplasmic-HMGB1 (high-mobility group box 1), a pro-type-2 inflammatory alarmin, and granulocytic inflammation. Aberrant Tregs expressed lower levels of CD39, an ectonucleotidase that hydrolyzes extracellular ATP, a known inducer of alarmin release. Using cultured mouse AECs, we identify that healthy Tregs suppress allergen-induced HMGB1 translocation whereas this ability is markedly impaired in aberrant Tregs. Thus, defective Treg programming in infancy has durable consequences that underlie the association between bronchiolitis and subsequent asthma.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32066837     DOI: 10.1038/s41385-020-0268-8

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  45 in total

1.  T-cell activation during exacerbations: a longitudinal study in refractory asthma.

Authors:  E Mamessier; A Nieves; A-M Lorec; P Dupuy; D Pinot; C Pinet; D Vervloet; A Magnan
Journal:  Allergy       Date:  2008-09       Impact factor: 13.146

2.  Natural regulatory T cells in isolated early responders compared with dual responders with allergic asthma.

Authors:  Takashi Kinoshita; Adrian Baatjes; Steven G Smith; Benny Dua; Richard Watson; Tomotaka Kawayama; Mark Larche; Gail M Gauvreau; Paul M O'Byrne
Journal:  J Allergy Clin Immunol       Date:  2013-10-15       Impact factor: 10.793

3.  Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells.

Authors:  Elizabeth A Oczypok; Pavle S Milutinovic; John F Alcorn; Anupriya Khare; Lauren T Crum; Michelle L Manni; Michael W Epperly; Adriane M Pawluk; Anuradha Ray; Tim D Oury
Journal:  J Allergy Clin Immunol       Date:  2015-04-28       Impact factor: 10.793

4.  T-cell regulation during viral and nonviral asthma exacerbations.

Authors:  Agnieszka S Wegrzyn; Bogdan Jakiela; Beate Rückert; Marek Jutel; Mübeccel Akdis; Marek Sanak; Cezmi A Akdis
Journal:  J Allergy Clin Immunol       Date:  2015-01-17       Impact factor: 10.793

5.  Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity.

Authors:  Jason P Lynch; Rhiannon B Werder; Jennifer Simpson; Zhixuan Loh; Vivian Zhang; Ashraful Haque; Kirsten Spann; Peter D Sly; Stuart B Mazzone; John W Upham; Simon Phipps
Journal:  J Allergy Clin Immunol       Date:  2016-04-25       Impact factor: 10.793

6.  Identification of novel immune phenotypes for allergic and nonallergic childhood asthma.

Authors:  Diana Raedler; Nikolaus Ballenberger; Elisabeth Klucker; Andreas Böck; Ragna Otto; Olivia Prazeres da Costa; Otto Holst; Thomas Illig; Thorsten Buch; Erika von Mutius; Bianca Schaub
Journal:  J Allergy Clin Immunol       Date:  2014-09-13       Impact factor: 10.793

7.  Expression of CD39 mRNA is altered in the peripheral blood of patients with allergic asthma.

Authors:  Lin-Lin Wang; Ping-Hua Tang; Chao-Guo Shi; Ying-Huan Wan; Wei Tang; Xia-Xiao Hou; Na-Li Pan; Yu-Bao Shi; Qin-Lian Tao
Journal:  Biomed Rep       Date:  2013-11-06

8.  The functional insufficiency of human CD4+CD25 high T-regulatory cells in allergic asthma is subjected to TNF-alpha modulation.

Authors:  Y-L Lin; C-C Shieh; J-Y Wang
Journal:  Allergy       Date:  2008-01       Impact factor: 13.146

9.  Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.

Authors:  Eleanor M Ling; Trevor Smith; X Dao Nguyen; Carol Pridgeon; Margaret Dallman; Justine Arbery; Victoria A Carr; Douglas S Robinson
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

10.  Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms.

Authors:  Timothy S C Hinks; Xiaoying Zhou; Karl J Staples; Borislav D Dimitrov; Alexander Manta; Tanya Petrossian; Pek Y Lum; Caroline G Smith; Jon A Ward; Peter H Howarth; Andrew F Walls; Stephan D Gadola; Ratko Djukanović
Journal:  J Allergy Clin Immunol       Date:  2015-03-05       Impact factor: 10.793

View more
  3 in total

1.  Serum periostin among infants with severe bronchiolitis and risk of developing asthma: A prospective multicenter cohort study.

Authors:  Makiko Nanishi; Michimasa Fujiogi; Robert J Freishtat; Claire E Hoptay; Cindy S Bauer; Michelle D Stevenson; Carlos A Camargo; Kohei Hasegawa
Journal:  Allergy       Date:  2022-01-17       Impact factor: 14.710

2.  Gut Microbiome and Metabolomics Profiles of Allergic and Non-Allergic Childhood Asthma.

Authors:  Ping Zheng; Kexing Zhang; Xifang Lv; Chuanhe Liu; Qiang Wang; Xuetao Bai
Journal:  J Asthma Allergy       Date:  2022-04-06

3.  Effect of Infant RSV Infection on Memory T Cell Responses at Age 2-3 Years.

Authors:  Tatiana Chirkova; Christian Rosas-Salazar; Tebeb Gebretsadik; Samadhan J Jadhao; James D Chappell; R Stokes Peebles; William D Dupont; Dawn C Newcomb; Sergejs Berdnikovs; Peter J Gergen; Tina V Hartert; Larry J Anderson
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.